Gov't plan to allow abortion pill imports draws mixed responses

On September 16, the government announced plans to conditionally allow imports of abortion pills, sparking a mix of responses from various groups. Women's groups welcomed the move, advocating for swift approval and wider access to the medications. Meanwhile, the medical community urged that safety measures and legal amendments be taken before the drugs are introduced.

The government's decision to move forward with the domestic introduction of the abortion pills stems from an interpretation by the Ministry of Government Legislation, which asserts that such approval does not breach the Mother and Child Health Act. The Ministry of Food and Drug Safety is presently examining the application for the import approval, which stipulates that the medications can be used within 63 days, or nine weeks, of pregnancy.

The government intends to proceed with the necessary procedures, prioritizing the safety, efficacy, and quality of the medications. Progressive civic groups, such as the Korea Women's Political Network, praised the government's initiative, labeling it a "meaningful step forward" in establishing a framework for women to access safe and verified medical services.

However, some experts contend that extending the allowable period of use from nine weeks to up to 12 weeks would further enhance access to abortion pills. Conversely, domestic medical and religious communities oppose the hasty introduction of the pills without the proper enactment of subsequent legislation. They emphasize the necessity of establishing proper sequences and conditions for the introduction of abortion pills, asserting that women's health rights can only be effectively safeguarded after ensuring secure access to medical care and systems for managing potential side effects.